Loading...
Loading...

by Avinash Health Products Pvt Ltd· 15S
SKU: 912940
You save ₹30 on this order
Inclusive of all taxes
SLEWTIN MF TABLET is used to manage type 2 diabetes (non-insulin-dependent
diabetes mellitus) in adult patients whose diabetes cannot be controlled by diet
and exercise alone and/or with other medicines used to manage diabetes (insulin
or sulphonylureas such as glimepiride and glipizide). It is a combination
of Metformin and Vildagli
Antidiabetic agents.
Before taking SLEWTIN MF TABLET, inform your doctor if you have liver, kidney,
or heart problems. It should be used during pregnancy only if advised by your
doctor, and it is not recommended for pregnant women. SLEWTIN MF TABLET is not
suitable for use in children and adolescents under 18 years of age, and it
should be used with caution in elderly patients (65 years of age and above).
Avoid consum
increase the risk of lactic acidosis. The most common side effects of taking
SLEWTIN MF TABLET are stomach pain, low blood sugar, and diarrhea. Contact your
doctor if any of the symptoms worsen.
SLEWTIN MF TABLET helps to control the blood sugar level, where Metformin makes
the body more sensitive to insulin (a hormone involved in glucose metabolism).
This helps our body cells utilize more of the circulating blood glucose.
Additionally, it can stop glucose production by the liver and reduce its
absor
actions of an enzyme called dipe
increases insulin secretion in the body. Collectively, SLEWTIN MF TABLET
controls blood sugar levels in patients with type II diabetes.
Stop taking SLEWTIN MF TABLET and contact your doctor immediately if you
experience any of the following side effects:
!### Pregnancy
Monitoring requiredSLEWTIN MF TABLET is not recommended for pregnant women unless it is considered
necessary.
!### Breastfeeding
ContraindicatedSLEWTIN MF TABLET is not recommended for use by breastfeeding women.
!### Driving and Using Machines
Use with CautionDo not drive or operate any machines if you experience dizziness after taking
SLEWTIN MF TABLET.
!### Alcohol
Consult your doctorConsum
TABLET since it may increase the risk of lactic acidosis.
!### Kidney
ContraindicatedSLEWTIN MF TABLET is not recommended in patients with severely reduced kidney
function.
!### Liver
ContraindicatedSLEWTIN MF TABLET is not recommended in patients with liver disease.
!### Allergy
ContraindicatedDo not take SLEWTIN MF TABLET if you are allergic (hypersensitive) to Metformin,
Vildagli
!### Heart Disease
ContraindicatedSLEWTIN MF TABLET is not recommended in patients who recently had a heart attack
or heart failure or any signs of heart problems such as serious blood
circulation problems or difficulty breathing.
!### Use In Pediatrics
ContraindicatedSLEWTIN MF TABLET is not recommended for use in children and adolescents less
than 18 years of age due to a lack of safety and effectiveness.
!### Use In Geriatrics
Use with CautionSLEWTIN MF TABLET should be used with caution in elderly patients above 65 years
of age, especially in patients with impaired kidney function. Your doctor will
adjust the dose depending on kidney function, and your kidney function will be
monitored regularly.
SLEWTIN MF TABLET is not recommended for you if you have:
Before taking SLEWTIN MF TABLET, inform your doctor if you have or had:
A. Drug-Drug interactions:
Before taking SLEWTIN MF TABLET, inform your doctor if you are taking any of
these medicines:
Overdosage:
If you or anyone else accidentally takes too much of SLEWTIN MF TABLET, consult
your doctor immediately. Overdosage symptoms of SLEWTIN MF TABLET might include
low blood sugar levels, lactic acidosis, muscle pain, mild and transient burning
or tickling sensations in the body, fever, and oedema.
| Drug | : | Metformin, Vildagli |
| Pharmacological Category | : | Bigu |
| Therapeutic Indication | : | Type II diabetes mellitus |
| Dosage Forms | : | Tablet |
A: SLEWTIN MF TABLET is a combination medication containing vildagli
metformin. It is used to manage type 2 diabetes mellitus in adults by improving
blood sugar control. Vildagli
secretion and decreases glucagon production, helping to regulate blood sugar
levels after meals. Metformin reduces glucose production in the liver and
improves the body’s response to insulin. Together, they are effective for
patients whose blood sugar levels are not controlled with metformin or
vildagli
A: The most common side effects of taking SLEWTIN MF TABLET Tablet are nausea,
vomiting, stomach pain, headache, low blood sugar, and diarrhea. Contact your
doctor if any of the symptoms worsen.
A: SLEWTIN MF TABLET (vildagli
purposes in diabetes management. Metformin is often the first-line treatment due
to its proven efficacy, safety, and cost-effectiveness. SLEWTIN MF TABLET is
added when metformin alone does not provide adequate blood sugar control.
SLEWTIN MF TABLET is more effective when combined with metformin (as in SLEWTIN
MF TABLET), as the dual therapy addresses blood sugar control from multiple
pathways. The choice depends on individual needs, tolerability, and doctor
recommendations.
A: SLEWTIN MF TABLET should be taken after food to minimize gastrointestinal
side effects like nausea or stomach upset. Following your doctor’s instructions
regarding timing and dosage is essential for o
A: SLEWTIN MF TABLET is generally weight-neutral, me
significantly cause weight gain or loss. However, metformin in the combination
may contribute to mild weight loss in some individuals by improving insulin
sensitivity and reducing appetite. Vildagli
on weight.
A: Constipation is not a common side effect of SLEWTIN MF TABLET. On the
contrary, metformin (part of SLEWTIN MF TABLET) is more likely to cause diarrhea
or loose stools. However, individual responses vary, and if constipation occurs,
it is usually mild and manageable with dietary changes and increased hydration.
A: The basic SLEWTIN MF TABLET tablet contains only vildagli
TABLET, however, is a combination of vildagli
or 1000 mg). Ensure you are prescribed the correct formulation based on your
treatment plan.
A: SLEWTIN MF TABLET should be taken as directed by your doctor. Typically:
Swallow the tablet whole with water, preferably after a meal to reduce stomach
upset.
Do not skip doses or stop the medication suddenly without consulting your
doctor.
Monitor your blood sugar levels regularly to ensure the medication is effective
A: The benefits of SLEWTIN MF TABLET include:
Effective blood sugar control: By combining two complementary mech
(vildagli
Weight neutrality: Suitable for overweight patients.
Low risk of hypoglycemia: Compared to sulfonylureas or insulin.
Convenience: Combining two medications in one tablet simplifies treatment.
Prevention of complications: Delays the onset of diabetes-related complications
like neuropathy and cardiovascular issues.
A: Vildagli
used with caution in patients with kidney impairment. Kidney function must be
monitored during treatment, as vildagli
kidneys. Metformin in SLEWTIN MF TABLET also requires caution due to the risk of
lactic acidosis in kidney impairment.
A: Metformin is the preferred first-line management for type 2 diabetes due to
its long-term safety, efficacy, and affordability. Vildagli
patients who need additional blood sugar control. The combination (as in SLEWTIN
MF TABLET) often provides better results than either drug alone. The choice
depends on individual needs and doctor recommendations.
A: Vildagli
Significant side effects occur, such as severe liver enzyme elevation or
allergic reactions.
It is ineffective in controlling blood sugar, and an alternative treatment is
needed.
Your doctor recommends discontinuation due to contraindications like kidney or
liver dysfunction.
Always consult your doctor before stopping the medication.
A: SLEWTIN MF TABLET is generally safe when used as prescribed. However,
patients with kidney, liver, or heart conditions should use it cautiously under
medical supervision. Regular monitoring of blood sugar levels, kidney function,
and liver enzymes is essential to ensure safety.
A: SLEWTIN MF TABLET is best taken after meals to reduce the risk of
gastrointestinal side effects. Follow your doctor’s timing and dosing
instructions for o
A: SLEWTIN MF TABLET 50/500 is typically taken once or twice daily, as
prescribed, after meals. Taking it with food helps improve tolerance to
metformin and reduces side effects like nausea.
A: Yes, Galvus and SLEWTIN MF TABLET are essentially the same as both contain
vildagli
marketed by another pharmaceutical company. Both are used for managing type 2
diabetes, and their effectiveness is similar. The choice between them depends on
availability, cost, and doctor recommendations.
SLEWTIN MF TABLET is used to manage type 2 diabetes (non-insulin-dependent
diabetes mellitus) in adult patients whose diabetes cannot be controlled by diet
and exercise alone and/or with other medicines used to manage diabetes (insulin
or sulphonylureas such as glimepiride and glipizide). It is a combination
of Metformin and Vildagli
Antidiabetic agents.
Before taking SLEWTIN MF TABLET, inform your doctor if you have liver, kidney,
or heart problems. It should be used during pregnancy only if advised by your
doctor, and it is not recommended for pregnant women. SLEWTIN MF TABLET is not
suitable for use in children and adolescents under 18 years of age, and it
should be used with caution in elderly patients (65 years of age and above).
Avoid consum
increase the risk of lactic acidosis. The most common side effects of taking
SLEWTIN MF TABLET are stomach pain, low blood sugar, and diarrhea. Contact your
doctor if any of the symptoms worsen.
SLEWTIN MF TABLET helps to control the blood sugar level, where Metformin makes
the body more sensitive to insulin (a hormone involved in glucose metabolism).
This helps our body cells utilize more of the circulating blood glucose.
Additionally, it can stop glucose production by the liver and reduce its
absor
actions of an enzyme called dipe
increases insulin secretion in the body. Collectively, SLEWTIN MF TABLET
controls blood sugar levels in patients with type II diabetes.
Stop taking SLEWTIN MF TABLET and contact your doctor immediately if you
experience any of the following side effects:
!### Pregnancy
Monitoring requiredSLEWTIN MF TABLET is not recommended for pregnant women unless it is considered
necessary.
!### Breastfeeding
ContraindicatedSLEWTIN MF TABLET is not recommended for use by breastfeeding women.
!### Driving and Using Machines
Use with CautionDo not drive or operate any machines if you experience dizziness after taking
SLEWTIN MF TABLET.
!### Alcohol
Consult your doctorConsum
TABLET since it may increase the risk of lactic acidosis.
!### Kidney
ContraindicatedSLEWTIN MF TABLET is not recommended in patients with severely reduced kidney
function.
!### Liver
ContraindicatedSLEWTIN MF TABLET is not recommended in patients with liver disease.
!### Allergy
ContraindicatedDo not take SLEWTIN MF TABLET if you are allergic (hypersensitive) to Metformin,
Vildagli
!### Heart Disease
ContraindicatedSLEWTIN MF TABLET is not recommended in patients who recently had a heart attack
or heart failure or any signs of heart problems such as serious blood
circulation problems or difficulty breathing.
!### Use In Pediatrics
ContraindicatedSLEWTIN MF TABLET is not recommended for use in children and adolescents less
than 18 years of age due to a lack of safety and effectiveness.
!### Use In Geriatrics
Use with CautionSLEWTIN MF TABLET should be used with caution in elderly patients above 65 years
of age, especially in patients with impaired kidney function. Your doctor will
adjust the dose depending on kidney function, and your kidney function will be
monitored regularly.
SLEWTIN MF TABLET is not recommended for you if you have:
Before taking SLEWTIN MF TABLET, inform your doctor if you have or had:
A. Drug-Drug interactions:
Before taking SLEWTIN MF TABLET, inform your doctor if you are taking any of
these medicines:
Overdosage:
If you or anyone else accidentally takes too much of SLEWTIN MF TABLET, consult
your doctor immediately. Overdosage symptoms of SLEWTIN MF TABLET might include
low blood sugar levels, lactic acidosis, muscle pain, mild and transient burning
or tickling sensations in the body, fever, and oedema.
| Drug | : | Metformin, Vildagli |
| Pharmacological Category | : | Bigu |
| Therapeutic Indication | : | Type II diabetes mellitus |
| Dosage Forms | : | Tablet |
A: SLEWTIN MF TABLET is a combination medication containing vildagli
metformin. It is used to manage type 2 diabetes mellitus in adults by improving
blood sugar control. Vildagli
secretion and decreases glucagon production, helping to regulate blood sugar
levels after meals. Metformin reduces glucose production in the liver and
improves the body’s response to insulin. Together, they are effective for
patients whose blood sugar levels are not controlled with metformin or
vildagli
A: The most common side effects of taking SLEWTIN MF TABLET Tablet are nausea,
vomiting, stomach pain, headache, low blood sugar, and diarrhea. Contact your
doctor if any of the symptoms worsen.
A: SLEWTIN MF TABLET (vildagli
purposes in diabetes management. Metformin is often the first-line treatment due
to its proven efficacy, safety, and cost-effectiveness. SLEWTIN MF TABLET is
added when metformin alone does not provide adequate blood sugar control.
SLEWTIN MF TABLET is more effective when combined with metformin (as in SLEWTIN
MF TABLET), as the dual therapy addresses blood sugar control from multiple
pathways. The choice depends on individual needs, tolerability, and doctor
recommendations.
A: SLEWTIN MF TABLET should be taken after food to minimize gastrointestinal
side effects like nausea or stomach upset. Following your doctor’s instructions
regarding timing and dosage is essential for o
A: SLEWTIN MF TABLET is generally weight-neutral, me
significantly cause weight gain or loss. However, metformin in the combination
may contribute to mild weight loss in some individuals by improving insulin
sensitivity and reducing appetite. Vildagli
on weight.
A: Constipation is not a common side effect of SLEWTIN MF TABLET. On the
contrary, metformin (part of SLEWTIN MF TABLET) is more likely to cause diarrhea
or loose stools. However, individual responses vary, and if constipation occurs,
it is usually mild and manageable with dietary changes and increased hydration.
A: The basic SLEWTIN MF TABLET tablet contains only vildagli
TABLET, however, is a combination of vildagli
or 1000 mg). Ensure you are prescribed the correct formulation based on your
treatment plan.
A: SLEWTIN MF TABLET should be taken as directed by your doctor. Typically:
Swallow the tablet whole with water, preferably after a meal to reduce stomach
upset.
Do not skip doses or stop the medication suddenly without consulting your
doctor.
Monitor your blood sugar levels regularly to ensure the medication is effective
A: The benefits of SLEWTIN MF TABLET include:
Effective blood sugar control: By combining two complementary mech
(vildagli
Weight neutrality: Suitable for overweight patients.
Low risk of hypoglycemia: Compared to sulfonylureas or insulin.
Convenience: Combining two medications in one tablet simplifies treatment.
Prevention of complications: Delays the onset of diabetes-related complications
like neuropathy and cardiovascular issues.
A: Vildagli
used with caution in patients with kidney impairment. Kidney function must be
monitored during treatment, as vildagli
kidneys. Metformin in SLEWTIN MF TABLET also requires caution due to the risk of
lactic acidosis in kidney impairment.
A: Metformin is the preferred first-line management for type 2 diabetes due to
its long-term safety, efficacy, and affordability. Vildagli
patients who need additional blood sugar control. The combination (as in SLEWTIN
MF TABLET) often provides better results than either drug alone. The choice
depends on individual needs and doctor recommendations.
A: Vildagli
Significant side effects occur, such as severe liver enzyme elevation or
allergic reactions.
It is ineffective in controlling blood sugar, and an alternative treatment is
needed.
Your doctor recommends discontinuation due to contraindications like kidney or
liver dysfunction.
Always consult your doctor before stopping the medication.
A: SLEWTIN MF TABLET is generally safe when used as prescribed. However,
patients with kidney, liver, or heart conditions should use it cautiously under
medical supervision. Regular monitoring of blood sugar levels, kidney function,
and liver enzymes is essential to ensure safety.
A: SLEWTIN MF TABLET is best taken after meals to reduce the risk of
gastrointestinal side effects. Follow your doctor’s timing and dosing
instructions for o
A: SLEWTIN MF TABLET 50/500 is typically taken once or twice daily, as
prescribed, after meals. Taking it with food helps improve tolerance to
metformin and reduces side effects like nausea.
A: Yes, Galvus and SLEWTIN MF TABLET are essentially the same as both contain
vildagli
marketed by another pharmaceutical company. Both are used for managing type 2
diabetes, and their effectiveness is similar. The choice between them depends on
availability, cost, and doctor recommendations.